ADMP - アダミス・ファ―マス―ティカルズ （Adamis Pharmaceuticals Corporation） アダミス・ファ―マス―ティカルズADMPのチャート
ADMPの企業情報
| symbol | ADMP |
|---|---|
| 会社名 | Adamis Pharmaceuticals Corp. （アダミス・ファ―マス―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company''s product portfolio includes specialty pharmaceutical products such as Epinephrine pre-filled syringe (PFS) APC-5000 dry powder inhaler (DPI) APC-1000 and APC-2000 and biotechnology products such as TeloB-VAX (vaccine) APC-100 APC-200 and APC-300. The Company''s lead product candidate the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe or the Epinephrine PFS is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology. アダミス・ファ―マス―ティカルズは米国の医薬品会社。アナフィラキシ―(急性の全身過敏症)、喘息、慢性閉塞性肺疾患、アレルギ―性鼻炎治療のネピネフリン自己注射剤、ドライパウダ―吸入器、吸入ステロイド薬の治験を行う。また、前立腺がんのテロメラ―ゼ阻害剤を治験中。本社はカリフォルニア州サンディエゴ。 Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. The company's SYMJEPI (epinephrine) Injection products are approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis' naloxone injection product candidate, ZIMHI, for the treatment of opioid overdose is currently under FDA review. Adamis is developing additional products, including treatments for acute respiratory diseases, such as COVID-19, influenza, asthma, and COPD. The company's subsidiary, US Compounding Inc., compounds sterile prescription drugs, and certain nonsterile drugs for human and veterinary use by hospitals, clinics, surgery centers, and vet clinics throughout most of the United States. Forward Looking Statements |
| 本社所在地 | 11682 El Camino Real Suite 300 San Diego CA 92130 USA |
| 代表者氏名 | Richard C. Williams リチャード・C・ウィリアムズ |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 858-997-2400 |
| 設立年月日 | 32660 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 126人 |
| url | www.adamispharmaceuticals.com |
| nasdaq_url | https://www.nasdaq.com/symbol/admp |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -28.29893 |
| 終値（lastsale） | 3.09 |
| 時価総額（marketcap） | 146130296.22 |
| 時価総額 | 時価総額（百万ドル） 144.23860 |
| 売上高 | 売上高（百万ドル） 13.32986 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 145.65953 |
| 当期純利益 | 当期純利益（百万ドル） -22.70772 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Adamis Pharmaceuticals Corp revenues increased 4% to $7.1M. Net loss increased 61% to $17.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $2.7M to $7.1M (expense) Selling general_administrative expense increase of 14% to $12.8M (expense). |
ADMPのテクニカル分析
ADMPのニュース
Adamis phase 2/3 trial of Tempol for COVID-19 gets safety board''s nod 2022/02/28 14:47:58 Seeking Alpha
Adamis Pharmaceuticals <> said the Data Safety Monitoring Board ((DSMB)) determined that its phase 2/3 trial of Tempol to treat COVID-19 can continue as no safety or clinical…
Adamis Pharmaceuticals'' Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment Expectations 2022/02/28 12:30:00 Benzinga
SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced that due to the acceleration of patient enrollment in the double-blind placebo controlled Phase 2/3 trial for Tempol for the treatment of COVID-19, an ad-hoc meeting of the Data Safety Monitoring Board (DSMB) was held to evaluate interim clinical and safety data for the trial. The DSMB is composed of subject matter experts and can unblind the data to determine the treatment effects of the subjects in the trial. Based on an analysis of the data, the DSMB determined that the study can continue, as there were no safety or clinical concerns identified. The data from the first 50 subjects will be reviewed again in March when the DSMB will examine additional clinical and safety data as part of the first planned interim analysis. "We are pleased with the progress of the trial, which has already exceeded the required number of subjects (124) for the second planned interim DSMB analysis," said Dr.
Thinking about buying stock in Pluristem Therapeutics, DiDi Global, Robinhood Markets, Bitfarms, or Adamis Pharmaceuticals? 2022/01/10 15:55:00 Benzinga
NEW YORK , Jan. 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PSTI, DIDI, HOOD, BITF, and ADMP. Full story available on Benzinga.com
Is It Overvalued? Look at the P/S Ratio: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Globalstar, Inc. (AMEX:GSAT) 2021/12/20 00:53:45 Stock Equity
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) with the stream of 3.88% also noticed, India Globalstar, Inc. (AMEX:GSAT) encountered a rapid change of 4.92% in the last hour of Fridays trading session. Adamis The post Is It Overvalued? Look at the P/S Ratio: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Globalstar, Inc. (AMEX:GSAT) appeared first on Stocks Equity .
Adamis Pharmaceuticals (NASDAQ:ADMP) Stock Crosses Below 200 Day Moving Average of $1.00 2021/12/19 12:22:41 Dakota Financial News
Adamis Pharmaceuticals Co. (NASDAQ:ADMP) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.00 and traded as low as $0.62. Adamis Pharmaceuticals shares last traded at $0.65, with a volume of 1,022,765 shares. A number of equities analysts have weighed in []
Is It Overvalued? Look at the P/S Ratio: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Globalstar, Inc. (AMEX:GSAT) 2021/12/20 00:53:45 Stock Equity
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) with the stream of 3.88% also noticed, India Globalstar, Inc. (AMEX:GSAT) encountered a rapid change of 4.92% in the last hour of Fridays trading session. Adamis The post Is It Overvalued? Look at the P/S Ratio: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Globalstar, Inc. (AMEX:GSAT) appeared first on Stocks Equity .
Adamis Pharmaceuticals (NASDAQ:ADMP) Stock Crosses Below 200 Day Moving Average of $1.00 2021/12/19 12:22:41 Dakota Financial News
Adamis Pharmaceuticals Co. (NASDAQ:ADMP) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.00 and traded as low as $0.62. Adamis Pharmaceuticals shares last traded at $0.65, with a volume of 1,022,765 shares. A number of equities analysts have weighed in []
Adamis Pharmaceuticals (NASDAQ:ADMP) Raised to Hold at Zacks Investment Research 2021/12/13 07:18:45 Transcript Daily
Zacks Investment Research upgraded shares of Adamis Pharmaceuticals (NASDAQ:ADMP) from a sell rating to a hold rating in a research note published on Friday morning, Zacks.com reports. According to Zacks, “Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the […]
Wobbling stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP 0.39%), Evolve Transition Infrastructure LP (AMEX:SNMP -7.90%) 2021/12/10 00:21:32 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Wobbling stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP 0.39%), Evolve Transition Infrastructure LP (AMEX:SNMP -7.90%) appeared first on Stocks Equity .
Have a sight on this: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Borr Drilling Limited (NYSE:BORR) 2021/12/06 08:27:38 Stock Equity
Adamis Pharmaceuticals Corporation (ADMP) with the stream of -6.69% also noticed, India Borr Drilling Limited (BORR) encountered a rapid change of -2.01% in the last hour of trading session. Adamis The post Have a sight on this: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Borr Drilling Limited (NYSE:BORR) appeared first on Stocks Equity .
Enamoring stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -1.69%), Ampio Pharmaceuticals, Inc. (AMEX:AMPE -2.47%) 2021/10/04 23:19:46 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enamoring stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -1.69%), Ampio Pharmaceuticals, Inc. (AMEX:AMPE -2.47%) appeared first on Stocks Equity .
Dazzling stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP 0.48%), Tiziana Life Sciences PLC (NASDAQ:TLSA -1.23%) 2021/09/22 22:57:02 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Dazzling stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP 0.48%), Tiziana Life Sciences PLC (NASDAQ:TLSA -1.23%) appeared first on Stocks Equity .
Enthralling stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -0.17%), AzurRx BioPharma, Inc. (NASDAQ:AZRX 2.66%) 2021/09/21 23:45:39 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enthralling stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -0.17%), AzurRx BioPharma, Inc. (NASDAQ:AZRX 2.66%) appeared first on Stocks Equity .
Hypnotizing stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -1.93%), China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC 0.00%) 2021/09/18 00:01:10 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Hypnotizing stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -1.93%), China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC 0.00%) appeared first on Stocks Equity .
Reasons You should Get this: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -0.72%), Galiano Gold Inc. (AMEX:GAU -2.96%) 2021/09/16 21:19:27 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Reasons You should Get this: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP -0.72%), Galiano Gold Inc. (AMEX:GAU -2.96%) appeared first on Stocks Equity .